Dr. James Cooper

James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics. Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education. In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems. Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society. View the full list of Dr. Cooper’s publications on PubMed.

Dr. Cooper is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles and participated in 1 clinical trial in the study of Venous Thromboembolism (VTE).